The stock has done great in 2013 with a huge 167% rise. Recently it has been a bit volatile, but that can be expected after such a huge run up. There were some high volume trading days, with good price action, but there was selling pressure at higher levels, perhaps due to profit booking. In fact, it has been a great year for several of the companies where Dr. Frost has a stake with double & even triple digit returns. His investments in Biozone Pharmaceuticals (BZNE), which owns the high potential QuSomes drug delivery technology, has been in the news recently. Castle brands is expected to do better over the next few quarters. A recent article on seekingalpha mentioned that the company is expected to turn profitable by March 2014, and the growth in the market will help it post good growth in top-line. There are risks associated with such investments as things may not work out as per plan, but the rewards are equally commensurate in case the promises are fulfilled. So those with a long term perspective and the required risk appetite can initiate a position in the stock. It is important to remember that the track record so far has not been that great as the company has been reporting net losses for several years. It carries a huge accumulated deficit. There are risks related to liquidity and dilution concerns. However, the expected profitability, experienced management, and expected high sales growth could help mitigate these risks over time. According to the author, Castle Brands has a strong portfolio of premium brands, and has strong potential for developing a break-out brand success and attract new premium brands. It could cross $1 if it is able to achieve profitability by early next year as per expectations.
We almost hit $1.00 recently. Break through $1.00 and ROX could really run. Look at the trading activity in SafeStitch Medical another Dr Frost pick. .69 to $1.49 over TWO trading days in early August. If ROX turns a profit and a few upgrades follow we could do well.....imo